Manufacture

The pipeline of early-stage CRISPR therapeutics is huge, but advancing these innovations will require a multifaceted strategy.

Dive into our top articles in biopharma and bioprocessing, from the promise of X-ray sterilization to the challenges of space-based biomanufacturing.

The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact

How digital technology has, and will continue to, augment scientific data collection and discovery

We get more details on the ready-to-use technologies alliance forged between Schott Pharma, Gerresheimer, and Stevanato.

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?

How CRISPR can change the way we design and produce antibodies.

Developing science is good; developing successful commercialization strategies is great.

Cell therapy has come a long way since the 1930s. Next, we need to find a way to bring the costs down by using allogeneic approaches.

A new drug delivery technique could eliminate needles from the vaccination process, as well as help the world prepare for the next pandemic.